
IJTLD Chronic Respiratory Disease (IJTLD CRD) is a new open access journal (fully compliant with Plan S).
Featuring the latest research on chronic lung conditions in low- and middle-income countries, IJTLD CRD improves access to knowledge to influence policy and practice for better health. Each issue provides a mix of articles, including: post TB lung disease (PTLD), asthma, COPD, impact of air pollution, lung damage in smokers, interstitial lung disease, bronchiectasis, long COVID, sleep apnoea, occupational lung disease and interventional pulmonology.

We encourage authors working on chronic respiratory disease to submit their latest research on all aspects of the management and care of patients. We will consider Editorials, Meeting Reports, Original Research (including methodology papers and qualitative research), Reviews, Viewpoints, Study Protocols, Case Series, Case Reports and Letters.
We are particularly keen to promote research on early diagnosis and treatments – including the latest therapeutic advances that have relevance across a wide range of respiratory conditions. Our aim is to highlight the importance of these conditions to influence policymakers and improve clinical care in LMICs.
For all queries please e-mail the Editorial team at journal@theunion.org.
Sponsorship
Supplements and article series are a highly-effective way of highlighting a specific topic to researchers, clinicians and decision makers in respiratory health.
Being an Open Access journal, IJTLD CRD has no barriers to access and can reach readers in health centres, medical, university and pharmaceutical institutes, along with civil society, patients and carers.
All content will be freely available and acknowledge the sponsors support and readers will receive emails to highlight sponsored content.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD, IJTLD OPEN and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
Inhaled Medicines Intervention Statement 79th World Health Assembly
The Union hosted an official side event at the 79th World Health Assembly, titled 'From Global Commitments to Integrated Lung Health Action: Advancing early diagnosis of lung cancer and access to inhaled medicines for COPD and asthma'. The session was co-hosted with the Ministry of Health Malaysia, Forum of International Respiratory Societies (FIRS) and Union for International Cancer Control.
During the side event, Cassandra Kelly-Cirino delivered the following intervention on behalf of The Union and FIRS.
Important step forward in UK tobacco control
As global health leaders, hosts of the World Conference on Tobacco Control 2025 and authors of the Dublin Declaration, The Union…
Compliance with intermittent preventive malaria treatment in pregnancy at a tertiary hospital in Sierra Leone
In this article, part of the TB, HIV and Malaria Series to be published in the Q2 issue of PHA, the authors examine uptake of intermittent preventive treatment in pregnancy in Sierra Leone, showing low compliance with the recommended minimum of three doses, largely associated with insufficient antenatal care contacts.
Parenteral artesunate compliance and hospital outcomes in children under-five with suspected severe malaria in Sierra Leone
In this article, part of the TB, HIV and Malaria Series to be published in the Q2 issue of PHA, the authors assess adherence to national severe malaria management guidelines in children under five in Sierra Leone and its association with hospital outcomes, highlighting suboptimal artesunate dosing and related adverse outcomes.
